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A standalone bioreactor system 
to deliver compressive load under 
perfusion flow to hBMSC-seeded 
3D chitosan-graphene templates
Joseph Lovecchio  1,2,3*, Paolo Gargiulo  1, Jose Luis Vargas Luna1,4,7, 
emanuele Giordano2,3,5,8 & Ólafur eysteinn Sigurjónsson1,6,8
The availability of engineered biological tissues holds great potential for both clinical applications and 
basic research in a life science laboratory. A prototype standalone perfusion/compression bioreactor 
system was proposed to address the osteogenic commitment of stem cells seeded onboard of 3D 
chitosan-graphene (CHT/G) templates. Testing involved the coordinated administration of a 1 mL/min 
medium flow rate together with dynamic compression (1% strain at 1 Hz; applied twice daily for 30 min) 
for one week. When compared to traditional static culture conditions, the application of perfusion and 
compression stimuli to human bone marrow stem cells using the 3D CHT/G template scaffold induced 
a sizable effect. After using the dynamic culture protocol, there was evidence of a larger number of 
viable cells within the inner core of the scaffold and of enhanced extracellular matrix mineralization. 
These observations show that our novel device would be suitable for addressing and investigating the 
osteogenic phenotype commitment of stem cells, for both potential clinical applications and basic 
research.
Tissue engineering (TE) strategies aiming at enhancing bone repair and regeneration are anticipated to become a 
standard clinical treatment in the future1. However, consensus has yet to be reached about fast, clean, and repro-
ducible procedures to precondition tissue engineered (TEed) constructs towards the bone phenotype. Bone native 
tissue is regularly subjected to mechanical cues, such as bending and compression elicited by physical activity, 
and to shear stress resulting from interstitial fluid movement as a consequence of loading2. The conversion of 
these physical stimuli into molecular signals and biological responses, which is referred to as mechanotransduc-
tion, drives molecular cascades of events triggering bone remodelling3,4. Accordingly, an appropriate mechanical 
loading of cells in culture promotes their expansion5, along with mineralized extracellular matrix (ECM) produc-
tion6–8. Cell physical triggering can be obtained via dedicated actuators - usually referred to as bioreactor systems 
- addressing a specific tissue phenotype according to their setup configuration9–17. Thus, including the processing 
of a bone TEed construct in a dedicated bioreactor system might be a viable translational medicine strategy. 
Building on our experience8,18–22,41 we have developed a standalone perfusion and compression bioreactor system 
to enhance the cell viability and ECM mineralization of mesenchymal stem cells (MSCs) cultured within 3D 
chitosan graphene (CHT/G) scaffold templates. Other devices have been described in the literature23–27, but none 
of these can simultaneously provide standalone incubator functionality, automatic media exchange, and online 
monitoring of the TEed construct.
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The bioreactor system described herein uses 3D-printed custom chambers to host the tissue constructs. These 
allow the administration of perfusion flow through a dedicated peristaltic pump and application of a compres-
sive axial deformation through a custom-made mechanical loading platform driven by a precise stepper motor. 
Moreover, an automatic media replacement system is included to minimize the cell culture contamination risk. 
Finite element analysis was used to determine the perfusion and compression input parameters to be adminis-
tered to the TEed constructs. Enhanced cell viability and initial ECM mineralization was evident as early as 1 
week into treatment, indicating that this prototype may be suitable to implement as a standard method for rapidly 
inducing and/or investigating osteogenic phenotype commitment.
Results
The bioreactor system detailed in this manuscript is a novel standalone device that allows culturing of 3D cell 
constructs within a controlled environment, where tightly regulated medium perfusion and scaffold compression 
are intended to sustain human bone marrow-derived mesenchymal stem cell (hBMSC) survival, proliferation, 
and commitment towards an osteogenic phenotype.
In its final layout, the prototype bioreactor system, shown in Fig. 1c, consists of a sturdy unibody Plexiglas case 
(with dimensions of 80 × 60 × 25 cm, length × width × height) containing all the components for operating the 
relevant mechanical actuation. Specifically, perfusion through the biocompatible materials used for the cell inter-
facing environment (silicon Tygon® tubing and polymeric TuskT® culture units) is driven by a WELCO WP10 
peristaltic pump (Fig. 1a). Compression is actuated via a custom-made aluminium mechanical loading unit (with 
dimensions of 20 × 5 × 12 cm; Figs 1a–5,d and 2) equipped with a Songyang NEMA-17 hybrid bipolar stepping 
motor delivering frequency- and displacement-controlled axial deformation.
To this aim, the motor includes a lead screw (Fig. 2–2) that drives the vertical movement of an integrated 
plate hosting multiple culture units/chambers on top (Fig. 2–3). These are in contact with adjustable pistons 
(Fig. 2–4) intended to compress the scaffolds contained within the chambers along with the plate strokes. The 
design includes the option of a load cell (Fig. 2–5) that can be used for online monitoring of the scaffold Young’s 
modulus.
Up to six 300-µL culture units (Fig. 3a) can operate in parallel alignment (Fig. 1a–5). Each culture chamber 
can host a single 3D scaffold, maintained under continuous medium flow and cyclic compression. Each culture 
unit can easily be disconnected from the perfusion line, thanks to the use of Spiros®/MicroClave® connectors 
that allow the risk of leakage from the fluid circuit (Fig. 3a) to be avoided. This last feature supports the option 
of carrying out additional vital analysis of the TEed constructs outside of the apparatus; the culture units can 
later be reconnected to the apparatus to resume mechanical stimulation. The medium temperature and pH are 
constantly monitored and maintained at 37 °C and 7.4, respectively, within the device. This removes the need for 
Figure 1. Bioreactor system layout. (a) Equipment diagram showing the front view of the bioreactor system 
set-up. 1: CO2 tank; 2: automatic media replacement peristaltic pumps; 3: perfusion peristaltic pump; 4: 
measurement chamber with temperature and pH sensors inside and heating pad below; 5: mechanical loading 
unit; 6: fresh and waste media bottles. (b) Side view of the bioreactor system (see (a) for details); (c) Actual 
bioreactor prototype; (d) Detail of the cell culture perfusion/compression unit. Scale bars: (a–c) = 10 cm; 
(d) = 1 cm.
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a dedicated cell culture incubator, allowing the device to be located on a standard lab benchtop. Culture medium 
replacement is automatically carried out by additional peristaltic pumps (Fig. 1a–2), which remove 80% of the 
exhausted medium, by volume, into the waste media bottle and add the same quantity of fresh medium from the 
fresh media bottle (Fig. 1a–6,b) every three days.
A user-friendly graphical user interface (GUI) (Fig. 4) allows easy tuning of all relevant parameters (i.e. tem-
perature, perfusion flow, axial deformation, and frequency) with simultaneous feedback control of temperature 
and pH values within the cell culture.
Tuning bioreactor system operation parameters according to chitosan-graphene mechanical 
properties. An in silico evaluation was carried out to estimate the shear and compressive stresses affecting the 
tissue constructs as a result of specific flow rate/axial deformation values (Table 1). Parameters resulting in a com-
pressive stress corresponding to the lowest με physiological value (where με is the unit of the fractional change in 
dimension, within the range of 100–2000 με)28 were used as operating inputs for bioreactor system tuning.
Figure 3b shows the finite element model (FEM) geometry for the culture chamber (grey) and the scaffold 
(blue) used for the above assessment in our study, where CHT/G mechanical properties are assigned. Perfusion 
flow rate in the range of 1 to 5 mL/min, compression providing 1 to 5% axial deformation, and combinations of 
the above-mentioned values were tested. The measured outcomes are listed in Table 1.
Perfusion flow rates resulted in average shear stress values in the range of 10−6 to 10−5 Pa. The axial defor-
mation range explored resulted in average higher compressive stress values in the range of 100 to 101 Pa (corre-
sponding to a strain in the range of 190 to 935 με). The addition of perfusion flow did not affect the range of the 
average compressive stress values. A representative display of how perfusion flow (1 mL/min), compression (1% 
axial deformation), or perfusion and compression together (using the above-mentioned conditions) impact the 
scaffold is presented in Fig. 3c–e. The colour bar shows a relative range of stress levels from lower (blue) to higher 
(red) values. Figure 3c shows the shear stress values occurring onto scaffolds fibres with only perfusion applied. 
The resulting light blue color shows low shear stress, with average values of about 10−6 Pa. On the other hand, 
Fig. 3d,e, where compression was applied either alone or in combination with perfusion, show similar yellow/
orange colour distributions, which are associated with higher compressive stress values (average of about 100 Pa) 
than those elicited when only perfusion was applied. These results imply that adding perfusion flow appears not 
to affect the range of the average compressive stress values.
Bioreactor system culture effect on cell viability and matrix mineralization. Following the in 
silico evaluation (Table 1), the lowest average shear and compressive stress simulated value (2.08 Pa), obtained 
with a perfusion flow of 1 mL/min and a compression of 1% axial deformation at a frequency of 1 Hz, was used 
to set the bioreactor operational parameters, in accordance with other previously published protocols23–27. After 
an initial 7 days under traditional static culture conditions to promote hBMSC adhesion and proliferation over/
Figure 2. Mechanical loading unit. Layout of the unit used to apply mechanical compression onto seeded 
scaffolds hosted within the custom-made chambers. 1: aluminium case (20 × 5 × 12 cm); 2: stepper motor 
driving the attached compression plate; 3: custom-made chamber; 4: piston and piston locker; 5: load cell. Scale 
bar: 1 cm.
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Figure 3. Perfusion/compression culture chamber hosting a 3D scaffold. (a) Removable culture unit. (b) Finite 
element model (FEM)-modelled chamber (grey) and scaffold (blue). Also shown are the stresses impacting over 
the scaffold when (c) perfusion (1 mL/min), (d) compression (1% axial deformation), and (e) perfusion and 
compression (1 mL/min and 1% axial deformation) are applied. In (c), the predominance of a light blue color 
shows low-shear stress with average values of about 10−6 Pa. In (d,e), the predominance of a yellow/orange color 
distribution shows higher-compressive stresses, with average values of about 100 Pa.
Figure 4. Graphical User Interface. On/off switches, sliders and type-in boxes easily tune all the actuators; up/
down buttons align the scaffolds to the pistons; temperature, pressure and pH indicator show all the operative 
parameters deriving from the sensors; send, read and stop buttons set the communication to/from Arduino.
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within twelve CHT/G scaffolds, six TEed constructs were exposed to continuous perfusion flow within our device 
with compression applied twice daily for 30 min for 7 days. The remaining six constructs were maintained for the 
same time under traditional static culture conditions as a reference control to evaluate the effects of the bioreactor 
system on cell viability and ECM mineralization. One scaffold from the bioreactor system and one maintained in 
static condition were evaluated by the LIVE/DEAD® assay to measure cell viability.
Figure 5 shows cell distribution and viability inside the CHT/G scaffolds, comparing the static (Fig. 5a,b) and 
dynamic (Fig. 5c,d) cultures. Figures 5a through 5d qualitatively show the increased viability of hBMSCs under 
dynamic vs static conditions. Larger numbers of viable cells were obvious under dynamic culture conditions, 
Figure 5. Cell viability/proliferation within the 3D CHT/G scaffold under either static (control; a = (outer 
layer; b = inner layer) or dynamic (perfusion and compression; c = outer layer; d = inner layer) culture 
conditions. Corresponding maximum entropy threshold-based image segmentation is shown (e,f = static; 
g,h = dynamic). Quantitative analysis of the total amount of scaffold area covered by the live cells (green areas) 
and dead cells (red areas) is also shown (i = live cells; j = dead cells, where “side” corresponds to the outer layer 
and “center” corresponds to the inner layer). *Statistically significant difference (Student’s t-test; p < 0.05). Scale 
bar 50 μm.
Flow rate [mL/min]




0 — 5.95E-06 1.19E-05 1.79E-05 2.38E-05 2.97E-05
1 2.08 2.08 2.08 2.08 2.08 2.08
2 4.16 4.16 4.16 4.16 4.16 4.16
3 6.23 6.23 6.23 6.23 6.23 6.23
4 8.31 8.31 8.31 8.31 8.31 8.31
5 10.39 10.39 10.39 10.39 10.39 10.39
Table 1. Specific shear and compressive stress values [Pa] resulting from different perfusion flow rates and 
compressions. Data are expressed as average values and are calculated as the sum of the stress values measured 
at each point of the mesh divided by the number of points.
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along with consistently reduced numbers of dead cells, when compared to a traditional static culture protocol. A 
quantitative analysis of live or dead cells, in static (Fig. 5e,f) vs. dynamic (Fig. 5g,h) conditions within the outer 
(Fig. 5e,g) and inner (Fig. 5f,h) layers of the scaffold, was performed via maximum entropy threshold-based 
image segmentation to confirm this qualitative evidence. Figures 5i,j show the areas of the scaffolds that contain 
viable or dead cells. The effect of perfusion exchange enhancement under dynamic culture conditions was par-
ticularly evident within the inner scaffold core, where significantly more viable and less dead cells were present 
than under traditional culture conditions. On the other hand, an apparent absence of statistically significant dif-
ferences between static and dynamic culture conditions was observed in the outer scaffold layers.
To evaluate the bioreactor system culture effect on early commitment of the hBMSCs towards the osteogenic 
phenotype, mineralization was evaluated in TEed constructs via von Kossa staining of their texture, after 7 days 
under dynamic or static culture.
Figure 6 shows von Kossa staining within the core of static (Fig. 6a,b) and dynamic (Fig. 6c,d) culture con-
structs. The qualitative optical microscopy images (Fig. 6a,c) show a larger number of von Kossa black spots 
under dynamic conditions. This was confirmed by performing a quantitative analysis using the maximum 
entropy threshold-based image segmentation method; the total amount of scaffold area covered by the von Kossa 
black spots in static vs. dynamic conditions are shown in Fig. 6b,d, respectively. ECM mineralization was then 
quantified under static and dynamic (perfusion and compression) conditions (Fig. 6e). A statistically significant 
(p < 0.05) effect of the compression stimulus was evident within the core of the 3D CHT/G scaffolds maintained 
under dynamic culture conditions, where sizable ECM mineralization is present compared to under traditional 
culture conditions.
Discussion
Although TEed bone tissue has been viewed as a potential alternative to the conventional use of natural bone 
grafts, its effective translation to clinical practice is still impractical. Likely responsible for the delayed progress 
towards such a process are poorly standardized applicative protocols. In other words, there is still a need to 
define minimal expansion and commitment parameters to proceed towards successful mesenchymal stem cell 
(MSC) transfer, homing, and differentiation into the host tissue. Over the past decade, tissue engineering (TE) 
has undergone significant progress driven by the convergence of biology, materials science, chemistry, and engi-
neering strategies29. As a consequence, current biofabrication technologies have enabled the manufacturing of 
3D artificial tissue constructs. In this respect, a TE approach to heal bone defects will greatly profit from bone 
grafts based on substitutes primed in vitro and able to integrate with the host, where they will reach full final 
differentiation30.
To this aim, various biomaterials - both biomimetic synthetic polymers and biological molecules - manu-
factured via several fabrication techniques, have been used as ECM substitutes with adequate biological and 
mechanical properties able to provide support for cell attachment, proliferation, and differentiation31. Autologous 
human MSCs (more specifically, bone marrow-derived MSCs, or hBMSCs) are suitable candidates to populate 
scaffolds, as they show evidence of sustained osteogenic capacity32. Indeed, given their proliferation potential, 
biomolecular production, cell-to-cell signalling, and formation of the appropriate ECM, they efficiently differen-
tiate down the osteogenic path and also secrete paracrine factors that may aid in the survival and vascularization 
of engineered bone33. Mechanostimulation acts as a significant input to maintain and/or induce the bone pheno-
type34, while increasing culture diffusion regimens35. In particular, compressive loads act as a key physical cue in 
natural bone, significantly increasing osteogenic markers7, and can be delivered over cells onboard of a scaffold 
Figure 6. Optical microscopy images of ECM mineralization (Von Kossa staining) within the core of the 3D 
CHT/G scaffold under either static (a) or dynamic (perfusion and compression) (c). Corresponding maximum 
entropy threshold-based image segmentation is also shown (b,d). Quantitative analysis of the total amount of 
scaffold area covered by the von Kossa black spots is shown (e). *Statistically significant difference (Student’s 
t-test; p < 0.05). Scale bar = 250 μm.
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to address their phenotype commitment. Thus, a combination of appropriate cells, biomaterials/scaffolds, and 
physical stimulation can be considered a successful approach to translate bone TE into clinics.
A standard protocol to induce MSCs onboard of a 3D scaffold towards osteogenic lineage commitment is cru-
cial. Starting from this paradigm, the aim of this study was to develop a novel perfusion/compression bioreactor 
system as an efficient tool to standardize bone TE. Based on this idea, a bioreactor was designed as a compact unit 
including perfusion/compression in a standalone culture apparatus, which also features innovative properties 
such as automatic media replacement and removable culture units intended for real-time monitoring of devel-
oping TEed constructs. The use of Spiros®/MicroClave® locks, to easily connect/disconnect a culture chamber 
to/from the perfusion line, was designed to enable the user to easily perform specific evaluations of interest (e.g. 
spectrofluorometric analysis, fluorescence analysis, or X-ray μCT for 3D imaging analysis) on a given developing 
TEed construct at different time points during culturing. Perfusion was aimed at improving diffusive exchanges, 
i.e. nutrient uptake and waste product removal, while compression was applied to exert mechanical cues over 
the cells onboard the scaffold to address their phenotype commitment. The standalone apparatus was conceived 
in such a way as to avoid the use of a dedicated cell culture incubator: that is, to allow the use of the device on a 
standard lab benchtop.
Culture parameters (i.e. a temperature of 37 °C and pH of 7.4) were initially monitored for a week in order to 
verify the stability of the system (i.e. without detecting any drift in the parameters). Bioreactor component steri-
lization was carried out prior to beginning the culturing, and no contamination was detected during test period. 
Besides minimizing contamination, another benefit of the automatic media replacement protocol is that it allows 
the progressive replacement of the media (e.g. at a rate of 1 mL/hr), avoiding the stress on the cell culture that 
results from the bulk media changes typically done within traditional subculture procedures36.
An in silico evaluation was carried out to estimate the shear and compressive stresses affecting the scaffolds, 
and therefore the cells onboard, when perfusion and/or compression are applied. Ranges for perfusion flow (1 
to 5 mL/min) and compression (1 to 5% axial deformation) rates were selected based on published evidence23–27. 
No apparent turbulence was detected under these conditions. The resulting average shear and compressive stress 
values were estimated to be in the range of 10−6 to 101 Pa, depending on the perfusion and compression condi-
tions applied. The average compressive stress value, obtained under application of 1% axial deformation, was 
approximately six orders of magnitude higher than the average shear stress induced by applying only perfusion 
stimulus at 1 mL/min. This implies that when both perfusion and compression are applied, the perfusion shear 
stress is negligible compared to the compressive stress. Accordingly, a perfusion flow rate of 1 mL/min was applied 
during the experimental dynamic culture with the purpose of maintaining appropriate diffusive exchanges8. In 
addition, dynamic compression was applied twice per day, for 30 min each time, with a 1% axial deformation at 
1 Hz; this resulted in a strain of 190 με, which is at the lower end of the useful range to address osteogenic pheno-
type commitment, reported in the literature to be 100 to 2000 με28. In particular, a small number of loading cycles 
(i.e. 24 to 100 cycles per day), with frequencies in the range of 0.5 to 1 Hz, resulted in up to a 24% increase in bone 
cross-sectional area and up to a 45% increase in bone mineral content. The effects of perfusion and compression 
stimuli on cell viability and ECM mineralization were evaluated at different time points. Proliferation was inves-
tigated on day 3 of the dynamic culture period, i.e. day 10 of the entire culture protocol, through a cell viability 
assay. Both qualitative and quantitative data showed a larger amount of viable cells under dynamic culture con-
ditions, together with a consistently reduced number of dead cells when compared to a traditional static culture 
protocol; it is hypothesized that this is the result of the contribution of perfusion to improving nutrient exchange 
and waste removal. The improved cell viability suggests that cell growth and proliferation are more adequately 
sustained in our system than under standard culture conditions, in particular when nutrient diffusion into the 
core of a 3D TEed construct was considered.
Perfusion flow-induced shear stress is unlikely to be responsible for dead cell detachment, given its negli-
gible values (Table 1) and the scaffold’s “shield” effect over the cells. The level of early ECM mineralization was 
evaluated through von Kossa staining; qualitative and quantitative data confirmed that our bioreactor system 
transferred a suitable mechanical cue to the scaffold, which was translated into a sizable biological effect. Such an 
evidence asks for a future application of our bioreactor system to test different biomaterial scaffolds and cell line-
ages. We plan this fulfillment using a second generation device overcoming some limitations, i.e. its encumbrance 
and the Plexiglas wear, experienced with the present prototype.
conclusions
We developed and tested a novel standalone bioreactor system suitable to apply different perfusion (1 to 5 mL/
min) and compression (1 to 5% axial deformation at frequencies of 0.5 to 5 Hz) stimuli, to transfer significant 
inputs to hBMSCs seeded onto a 3D scaffold. Perfusion improved nutrient exchange and waste removal, resulting 
in increased cell viability, while cyclic compression loading enhanced ECM mineralization. These observations 
show that our novel device could be a potentially valuable a technology for addressing and investigating the 
osteogenic phenotype commitment of stem cells, both in view of possible clinical applications37 and for basic 
laboratory research protocols.
Materials and Methods
Bioreactor system design. Finite element modelling of stress distribution in a dynamic culture. A finite 
element model (FEM, COMSOL Multiphysics® Modeling Software, Stockholm, Sweden) was implemented to 
assess the stress distribution into 3D cell/scaffold constructs under perfusion and/or compression stimuli. All the 
components were obtained using primitive geometries and Boolean operations. The inner chamber had a diame-
ter of 6 mm and a height of 9 mm. The scaffold was 5 mm in diameter and 6 mm in height. The inlet/outlet diam-
eter was 3.2 mm. To approximate the medium properties, the inner volume of the well was modelled as water. 
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Navier-Stokes equations were set for the viscous fluid. Darcy’s law was used for the laminar fluid flow. Linear 
elasticity equations were set for the scaffold. A sensitivity study of the mesh was performed in order to obtain the 
most computationally efficient solution. The specific parameters listed in Table 2 were measured experimentally.
Bioreactor system architecture. A perfusion/compression bioreactor was designed and built with the 
aim of improving the growth and the osteogenic commitment of the stem cells seeded over a scaffold of interest. 
The bioreactor is a standalone system that can automatically run perfusion and compression protocols while 
monitoring and maintaining a stable temperature and pH. The Control Unit (CU) of the system is based on a 
micro-controller (ATmega2560, Atmel Corp., USA), which communicates with a Graphical User Interface (GUI) 
(implemented in LabView, National Instruments, USA) to configure the parameters of the system.
Culture chamber layout. Custom chambers, which host tissue constructs and allow perfusion and compression 
over cell-seeded 3D scaffolds, were fabricated to follow the geometry of a standard 96-plate single well (i.e. a 
cylinder with 300 µL volume) and 3D printed in a polymeric biocompatible material (TuskT®, Materialise HQ, 
Leuven, Belgium). Each chamber represents an independent detachable unit integrated into the perfusion line via 
Spiros/MicroClave connectors (ICUMed, San Clemente, CA, USA), as illustrated in Fig. 3a.
Standalone culture apparatus set-up. Two WPX1 peristaltic pumps (WELCO Co. Ltd., Tokyo, Japan) were used 
to supply fresh medium to and remove exhausted medium from the bioreactor circuit. The system controls both 
pumps to provide automatic handling of the fluid exchange, which facilitates medium replacement while decreas-
ing culture contamination risk due to human intervention.
The system temperature was maintained at 37 °C by a closed-loop control utilizing three heating pads distrib-
uted in key segments of the circuit and the feedback from a DS18B20 thermistor (Dallas Semiconductor, Dallas, 
TX, USA). Using a similar strategy, a gas mixture of 5% CO2, 20% O2, and 75% N was bubbled into the medium 
to guarantee a pH level of 7.4 pH, which was monitored by a BNC pH lab electrode probe (Phidgets Inc., Calgary, 
AB, Canada).
Perfusion/compression actuation design. A WP10 peristaltic pump (WELCO Co. Ltd.) was implemented to pro-
vide continuous nutrient delivery and waste removal to/from the TEed constructs. The perfusion flow rate can be 
adjusted up to 5 mL/min per single culture chamber, in accordance with referenced values25.
A NEMA-17 hybrid bipolar stepping motor (Songyang Machinery & Electronics Co. Ltd., Changzhou, China) 
enables controlled cyclic compression of the TEed scaffolds. The system allows the compression to be configured 
within the range of 1 to 5% at frequencies of 0.5 to 5 Hz. The parameters are set via the GUI and controlled auto-
matically by the CU.
3D cell culture setting and analysis. Human mesenchymal stem cell culture. Primary human bone 
marrow-derived mesenchymal stem cells (hBMSCs) were purchased (Lonza Inc., Allendale, NJ, USA) and used 
at passage #2 for the seeding onboard of 3D scaffolds and the subsequent 1 week culture either within our biore-
actor system or under conventional static conditions as a control. To this aim, the cells were initially expanded 
as a 2D monolayer in high glucose Dulbecco’s Modified Eagle Medium (DMEM) containing 0.1% penicillin/
streptomycin, 0.1 mM non-essential amino acids, and 10% foetal bovine serum. After two passages, the hBMSCs 
were trypsinized and counted in a haemocytometer using Trypan Blue staining to evaluate the number of dead 
cells. All reagents were purchased from Life Technologies (Carlsbad, CA, USA).
3D chitosan-graphene scaffolds. Graphene oxide was prepared according to Hummers and Offeman38 at the 
National Institute for Research and Development in Microtechnologies (Romania). Acetic acid (99.7%) and chi-
tosan (CHT) from crab shells were purchased from Sigma-Aldrich (St Louis, MO, USA). All materials were 
dissolved without further purification in double distilled (dd) water. 2.5 g CHT was mixed with 250 mL acetic 
acid solution (10% v/v in dd water) at 50 °C in order to form a homogeneous viscous solution. Further, graphene 
oxide, at a concentration of either 0.5 or 3 g/100 mL (w/v), was added to the CHT solution and mixed by ultra-
sonication for 1 h at room temperature (RT). The resulting homogeneous solution was casted onto transparent 
glass Petri dishes, then frozen overnight at −70 °C and freeze-dried for 2 days at −50 °C and 0.040 mbar. After 
sublimation of ice crystals by freeze-drying, the polymer structure became porous. The 3D dried materials were 




Young’s modulus 2E Em04 Pa
Poisson ratio 0.8 —
Density 60 kg/m3
Table 2. FEM parameters for 3D cell/scaffold constructs. Perfusion flow rates in the range of 1 to 5 mL/min, 
compression within 1 to 5% axial deformation, and combinations of above-mentioned values were tested in 
order to estimate the operating inputs for bioreactor system tuning.
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90 °C overnight. The obtained samples were then subjected to an advanced characterization of the bulk surface 
and to an in vitro biocompatibility assessment according to Meloan and Puchtler39.
3D cell culture. Chitosan-graphene (CHT/G) scaffolds (200 mL volume each) were seeded with hBMSCs 
(1 × 106 cells/mL) in a standard 24-well plate and maintained at conventional static culture conditions for 1 week. 
Afterwards, the scaffolds were placed either into the bioreactor system culture chambers or maintained under 
conventional static culture conditions, as above. The hBMSCs were then cultured for 1 additional week, in either 
dynamic or static culture, for a total of 14 days of culturing. The medium was formulated in high glucose DMEM, 
with 40 mg/mL proline (Sigma-Aldrich), 10% human platelet lysate (as a substitute for the traditionally-used 
foetal bovine serum as a soluble growth factor source; platelet lysate was obtained from the Blood Bank of the 
Landspitali University Hospital, Reykjavik, Iceland), and 0.1% penicillin/streptomycin (Life Technologies). The 
medium was supplemented with an osteogenic culture mix to provide final concentrations of 0.1% sodium pyru-
vate (Life Technologies), 50 mg/mL ascorbate 2-phosphate (Sigma-Aldrich), 0.1 mM dexamethasone, 1% ITS M 
premix (BD Biosciences, Bedford, MA), and 10 ng/mL TGFβ-3 (R&D Systems, Minneapolis, MN). The medium 
was changed every 3 days in both culture protocols. Perfusion/compression regimens applied to 3D cell/scaffold 
constructs in dynamic culture were identified through a FEM and are detailed further below.
LIVE/DEAD® cell viability assay. 100 μL of 2 μM calcein AM / 4 μM EthD-1 (Thermo Fisher Scientific, 
Waltham, MA, USA) in sterile tissue culture–grade phosphate-buffered saline (PBS) was administered on top of 
a microtome (cross section) of cellularized CHT/G scaffold, cut with a scalpel. Three sections, placed on top of a 
microscope coverslip, were incubated within a covered Petri dish, to prevent drying of the samples, for 1 h at RT 
in darkness. Following incubation, the samples were washed with PBS. Each wet coverslip was then mounted on 
top of a microscope slide and sealed with fingernail polish. Each sample was analysed under a fluorescence micro-
scope. Green calcein fluorescence (Ex/Em 494/517) was emitted by living cells, whereas Red EthD-1 fluorescence 
(Ex/Em 528/617) indicated dead cell nuclei.
von Kossa staining. A standard von Kossa staining protocol40 was used to quantify the deposition of calcium/
calcium salts occurring during ECM mineralization. Microtome sections from cellularized CHT/G scaffolds were 
fixed on the top of microscope slides in cold methanol for 15 to 20 min. After three PBS rinses, the slides were 
incubated with 5% silver nitrate solution under UV light. Reduced calcium could then be identified via the pres-
ence of metallic silver nodules, which appeared as black spots.
LIVE/DEAD® and von Kossa quantitative analysis. Quantitative analysis of cell viability and ECM minerali-
zation was performed on images acquired from cellularized CHT/G scaffold slices. Control (static culture) and 
dynamic (bioreactor system) data were compared. To this aim, images acquired with a Nikon TE 2000U optical 
microscope were processed, using ImageJ software (National Institute of Health, USA) in order to determine the 
size of the green or red (LIVE/DEAD® assay) and black (von Kossa staining) areas. These areas were calculated 
using the maximum entropy threshold-based image segmentation method. The total area (A) covered by specific 
spots of interest in the total scaffold slice surface was calculated using the Eq. (1),
= ⋅A np pd (1)2
Statistical analysis. A Shapiro-Wilk normality test was performed to confirm that the data followed a nor-
mal distribution. Student’s t-tests were used to determine significant differences between groups. The significance 
level was set at p <0.05. Results are presented as mean ± standard deviation.
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